Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1

Blood

Volumn 99, Issue 11, 2002, Pages 4030-4038

  Zhou, Quansheng ^a   Zhao, Ji ^a   Wiedmer, Therese ^a   Sims, Peter J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; SCRAMBLASE; SCRAMBLASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; HEMATOPOIETIC STEM CELL; HEMOSTASIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION;

EID: 0036624776     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-12-0271     Document Type: Article

References (27)

1. 2+-dependent transbilayer movement of phospholipid. J Biol Chem. 1996;271:17205-17210.
2. Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. Molecular cloning of human plasma membrane phospholipid scramblase: A protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem. 1997;272:18240-18244.
3. WiedmerT, Zhou QS, Kwoh DY, Sims PJ. Identification of three new members of the phospholipid scramblase gene family. Biochim Biophys Acta. 2000;1467:244-253.
4. Frasch SC, Henson PM, Kailey JM, et al. Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cδ. J Biol Chem. 2000;275:23065-23073.
5. Pastorelli C, Veiga J, Charles N, et al. IgE receptor type I-dependent tyrosine phosphorylation of phospholipid scramblase. J Biol Chem. 2001;276:20407-20412.
6. Sun J, Zhao J, Schwartz MA, Wang JYJ, Wiedmer T, Sims PJ. c-AbI tyrosine kinase binds and phosphorylates phospholipid scramblase 1. J Biol Chem. 2001;276:28984-28990.
7. Sun J, Nanjundan M, Pike LJ, Wiedmer T, Sims PJ. Plasma membrane phospholipid scramblase 1 is enriched in lipid rafts and interacts with the epidermal growth factor receptor. Biochemistry. In press.
8. Zhao J, Zhou Q, WiedmerT, Sims PJ. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J Biol Chem. 1998;273:6603-6606.
9. Fadeel B, Gleiss B, Högstrand K, et al. Phosphatiylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression. Biochem Biophys Res Commun. 1999;266:504-511.
10. Zhou QS, Zhao J, Al Zoghaibi F, et al. Transcriptional control of the human plasma membrane phospholipid scramblase 1 gene is mediated by interferon-α. Blood. 2000;95:2593-2599.
11. Kasukabe T, Okabe-Kado J, Honma Y. TRA1, a novel mRNA highly expressed in leukemogenic mouse monocytic sublines but not in nonleukemogenic sublines. Blood. 1997;89:2975-2985.
12. Silverman RH, Halloum A, Zhou A, et al. Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1. Cancer Res. 2002;62:397-402.
13. Jelinsky SA, Estep P, Church GM, Samson LD. Regulatory networks revealed by transcriptional profiling of damaged Saccharomyces cerevisiae cells: Rpn4 links base excision repair with proteasomes. Mol Cell Biol. 2000;20:8157-8167.
14. Der SD, Zhou AM, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc Natl Acad Sci U S A. 1998;95:15623-15628.
15. Zhou QS, Sims PJ, Wiedmer T. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome. Blood. 1998;92:1707-1712.
16. Tibbles HE, Vassilev A, Wendorf H, et al. Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation. J Biol Chem. 2001;276:17815-17822.
17. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem. 1988;263:18205-18212.
18. Aszodi A, Pfeifer A, Ahmad M, et al. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J. 1999;18:37-48.
19. 2. Blood. 2001;97:2469-2477.
20. Comfurius P, Williamson P, Smeets EF, Schlegel RA, Bevers EM, Zwaal RFA. Reconstitution of phospholipid scramblase activity from human blood platelets. Biochemistry. 1996;35:7631-7634.
21. Bevers EM, Comfurius P, Dekkers DWC, Zwaal RFA. Lipid translocation across the plasma membrane of mammalian cells. Biochim Biophys Acta. 1999;1439:317-330.
22. Sims PJ, Wiedmer T. Unraveling the mysteries of phospholipid scrambling. Thromb Haemost. 2001;86:266-275.
23. Weiss HJ. Scott syndrome: A disorder of platelet coagulant activity. Semin Hematol. 1994;31:312-319.
24. Winzeler EA, Shoemaker DD, Astromoff A, et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science. 1999;285:901-906.
25. McLemore ML, Grewal S, Liu F, et al. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity. 2001;14:193-204.
26. Duarte RF, Frank DA. SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways. Blood. 2000;96:3422-3430.
27. Smithgall TE, Briggs SD, Schreiner S, Lerner EC, Cheng H, Wilson MB. Control of myeloid differentiation and survival by Stats. Oncogene. 2000;19:2612-2618.